A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

CRISPR/Cas9 Gene Editing to Make Conditional Mutants of Human Malaria Parasite P. falciparum

10K views

⸱

DOI:

10.3791/57747

⸱

September 18th, 2018

* These authors contributed equally

In This Article

Summary

We describe a method for generating glmS-based conditional knockdown mutants in Plasmodium falciparum using CRISPR/Cas9 genome editing.

Abstract

Malaria is a significant cause of morbidity and mortality worldwide. This disease, which primarily affects those living in tropical and subtropical regions, is caused by infection with Plasmodium parasites. The development of more effective drugs to combat malaria can be accelerated by improving our understanding of the biology of this complex parasite. Genetic manipulation of these parasites is key to understanding their biology; however, historically the genome of P. falciparum has been difficult to manipulate. Recently, CRISPR/Cas9 genome editing has been utilized in malaria parasites, allowing for easier protein tagging, generation of conditional protein knockdowns, and deletion of genes. CRISPR/Cas9 genome editing has proven to be a powerful tool for advancing the field of malaria research. Here, we describe a CRISPR/Cas9 method for generating glmS-based conditional knockdown mutants in P. falciparum. This method is highly adaptable to other types of genetic manipulations, including protein tagging and gene knockouts.

Introduction

Malaria is a devastating disease caused by protozoan parasites of the genus Plasmodium. P. falciparum, the most deadly human malaria parasite, causes approximately 445,000 deaths per year, mostly in children under the age of five1. Plasmodium parasites have an intricate life cycle involving a mosquito vector and a vertebrate host. Humans first become infected when an infected mosquito takes a blood meal. Then, the parasite invades the liver where it grows, develops, and divides for approximately one week.After this process, the parasites are released into the bloodstream, where they undergo asexual replication in red ....

Access restricted. Please log in or start a trial to view this content.

Protocol

Continuous culture of P. falciparum requires the use of human RBCs, and we utilized commercially purchased units of blood that were stripped of all identifiers and anonymized. The Institutional Review Board and the Office of Biosafety at the University of Georgia reviewed our protocols and approved all protocols used in our lab.

1. Choosing a gRNA Sequence

  1. Go to CHOPCHOP (http://chopchop.cbu.uib.no/) and select 'Fasta Target'. Under 'Target', paste the 200 base pairs from the 3’ end of the open reading frame (ORF) of a gene and 200 base pairs from the start of the gene’s 3&#....

Access restricted. Please log in or start a trial to view this content.

Results

A schematic of the plasmids used in this method as well as an example of a shield mutation are shown in Figure 1. As an example of how to identify mutant parasites after transfection, results from PCRs for checking integration of the HA-glmS construct are shown in Figure 2. A representative image of a cloning plate is shown in Figure 3 to demonstrate the color change of the medium in the pre.......

Access restricted. Please log in or start a trial to view this content.

Discussion

The implementation of CRISPR/Cas9 in P. falciparum has both increased the efficiency of and decreased the amount of time needed for modifying the parasite's genome, compared to previous methods of genetic manipulation. This comprehensive protocol outlines the steps necessary for generating conditional mutants using CRISPR/Cas9 in P. falciparum. While the method here is geared specifically for the generation of HA-glmS mutants, this strategy can be adapted for a variety of needs, including t.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

We thank Muthugapatti Kandasamy at the University of Georgia (UGA) Biomedical Microscopy Core for technical assistance and Jose-Juan Lopez-Rubio for sharing the pUF1-Cas9 and pL6 plasmids. This work was supported by ARCS Foundation awards to D.W.C. and to H.M.K., UGA startup funds to V.M., grants from the March of Dimes Foundation (Basil O'Connor Starter Scholar Research Award) to V.M., and US National Institutes of Health grants (R00AI099156 and R01AI130139) to V.M. and (T32AI060546) to H.M.K.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Gene Pulser Xcell ElectroporatorBio-Rad1652660
Gene Pulser Xcell ElectroporatorBio-Rad165-2086We buy the ones that are individually wrapped
Sodium AcetateSigma-AldrichS2889-250g
DSM1Gift from Akhil Vaidya labGanesan et al. Mol. Biochem. Parasitol. 2011 177:29-34
TPP Tissue Culture 6 Well PlatesMIDSCITP92006
TPP 100 mm Tissue Culture Dishes (12 mL Plate)MIDSCITP93100
TPP Tissue Culture 96 Well PlatesMIDSCITP92096
TPP Tissue Culture 24 Well PlatesMIDSCITP92024
NEBuffer 2New England Biolabs#B7002S
NEBuffer 2.1New England Biolabs#B7202S
BtgZINew England Biolabs#R0703L
SacIINew England Biolabs#R0157L
HindIII-HFNew England Biolabs#R3104S
Afe1New England Biolabs#R0652S
Nhe1-HFNew England Biolabs#R3131L
T4 DNA PolymeraseNew England Biolabs#M0203S
500 mL Steritop bottle top filter unitMilliporeSCGPU10REYou can use any size that fits your needs
EGTASigmaE4378-100G
KClSigma-AldrichP9333-500g
CaCl2Sigma-AldrichC7902-500g
MgCl2Sigma-AldrichM8266-100g
K2HPO4FisherP288-500
HEPESSigma-AldrichH4034-500g
pMK-U6Generated by the Muralidharan Labn/a
pHA-glmSGenerated by the Muralidharan Labn/a
pUF1-Cas9Gift from the Jose-Juan Lopez-Rubio LabGhorbal et al. Nature Biotech 2014
GlucoseSigma-AldrichG7021-1KG
Sodium bicarbonateSigma-AldrichS5761-500G
Sodium pyruvateSigma-AldrichP5280-100G
HypoxanthineSigma-AldrichH9636-25g
Gentamicin ReagentGibco15710-064
ThymidineSigma-AldrichT1895-1G
PL6-eGFP BSDGenerated by the Muralidharan Lab
Puf1-cas9 eGFP gRNAGenerated by the Muralidharan Lab
NucleoSpin Gel and PCR Clean-upMacherey-Nagel740609.250
Albumax ILife TechnologiesN/AYou will want to try a few batches to find out what the parasites will grow in best
Human Red Blood CellsInterstate Blood Bank, IncEmail or call them directly for orderingWe typically use O+ blood
3D7 parasite lineAvailable upon requestN/A
Lysogeny Broth (LB)FisherBP1426-2You can make your own, it is not necessary to use exactly this
AmpicilinFisherBP1760-25We make a 1000X stock at 100mg/ml in water and store in the -20C
AmpicilinClonetechR050A
Anti-EF1alphaDr. Daniel Goldberg's LabWashington University in St. LouisYou can use your preferred loading control for western blots. This is just the one we use in our laboratory
Rat Anti-HA Clone 3F10, monoclonalMade by Roche, sold by Sigma11867423001You can use your preferred anti-HA antibody
0.6 mL tubesFisherAB0350
Fisher HealthCare* PROTOCOL* Hema 3* Manual Staining System (Fixative+Solution I and II)Fisher22-122-911You can also use giemsa stain
Fisherfines Premium Frosted Microscope Slides - Size: 3 x 1 in.Fisher12-544-3

References

  1. World Health Organization. World Malaria Report. , World Health Organization. Geneva. (2017).
  2. Miller, L. H., Baruch, D. I., Marsh, K., Doumbo, O. K. The pathogenic basis of malaria. Nature. 415 (6872), 673-679 (2002).
  3. Florentin, A., et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Plasmodium FalciparumGlmS KnockdownProtein TaggingGene KnockoutElectroporation TechniqueWestern Blot AnalysisImmunofluorescence AssayBlood Smear Preparation